43 Currently, these drugs are primarily in the development and clinical trial stages, but preliminary research results have shown their potential powerful effects in reducing blood sugar and body weight
However, weight loss is not always satisfactory and is often not maintained over time, indicating that continual research is needed
In the SURMOUNT-1 body-composition substudy, about 74% of the total weight lost on tirzepatide came from fat mass rather than lean mass, and MRI showed visceral (intra-abdominal) fat fell by roughly a third, substantially more than placebo
Lets take a look at the science so far
Your diabetes care team may need to adjust doses of concurrent medications to reduce hypoglycaemia risk
And what I found was eye-opening